« Back
Home /
MAPT Antibody (OASC00241)

MAPT Antibody (OASC00241)

Item no.	OASC00241
Manufacturer	AVIVA Systems Biology
Amount	50ug/50ul
Category	Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Antibodies Immunofluorescence Primary Antibodies
Type	Antibody Polyclonal
Format	Rabbit IgG in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Applications	IF
Specific against	Human, Mouse, Rat
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Similar products	MAPT
Available
description	Tau (Ab-356) Antibody
gene_symbol	MAPT
protein_accession_num	http://www.ncbi.nlm.nih.gov/protein/NP_001116538.2
swissprot_id	http://www.uniprot.org/uniprot/P10636
Observed Species Reactivity	Human, Mouse, Rat
product_format	Rabbit IgG in phosphate buffered saline (without Mg²⁺ and Ca²⁺), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
gene_id	4137
reconstitution_and_storage	Store at -20 C/1 year
Predicted Homology Based on Immunogen Sequence	Human, Mouse, Rat
specificity	Tau (Ab-356) Antibody detects endogenous levels of total Tau protein.
purification	The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
immunogen	The immunogen for Anti-MAPT antibody is: the antiserum was produced against synthesized non-phosphopeptide derived from human Tau around the phosphorylation site of serine 356(I-G-SP-L-D).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50ug/50ul

available

Delivery expected until 8/30/2024